Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOBUTAMINE vs DOCETAXEL ANHYDROUS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOBUTAMINE vs DOCETAXEL ANHYDROUS: Safety Overview

Metric DOBUTAMINE DOCETAXEL ANHYDROUS
Total FAERS Reports 1,632 1,084
Deaths Reported 611 5
Death Rate 37.4% 0.5%
Hospitalizations 809 10
Average Patient Age 65.0 yrs 55.6 yrs
% Female Patients 27.1% 99.2%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Hikma Pharmaceuticals USA Inc. Mylan Institutional LLC
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued N/A